11 June 2026
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants
Advising firms
Deal team
14 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Roeder Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Caitlin Nguyen | Latham & Watkins LLP | Associate | corporate | Not stated |
| Sheen Moaleman | Latham & Watkins LLP | Associate | corporate | Not stated |
| Isaac Gonzalez | Latham & Watkins LLP | Associate | corporate | Not stated |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property and technology transactions | San Diego |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property and technology transactions | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Derek Gumm | Latham & Watkins LLP | Associate | tax | Not stated |
| Tessa Young | Latham & Watkins LLP | Associate | tax | Not stated |
| John Manthei | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | FDA regulatory | Bay Area |
| Amy Speros | Latham & Watkins LLP | Counsel | FDA regulatory | San Diego |
| James Metz | Latham & Watkins LLP | Partner | executive compensation and benefits | Bay Area |
11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 300m (US$300 million)
- What the figure measures
- Issue size
- Client
- IDEAYA Biosciences, Inc.Issuer
- Counterparties
- Not stated